CD56 (MOC-1) (clone MOC-1), anti-human, mouse
€564.00
In stock
SKU
ARP-21-5209
Catalog Number: 21-5209
Size: 100 µg
Isotype: Mouse IgG1
Size: 100 µg
Isotype: Mouse IgG1
Background:
Lung cancer is a heterogeneous disease, which can be subdivided into five major tyoes based on histopathological criteria like squamous cell carcinomas, adenocarcinoma, large cell carcinoma, adenosquamous carcinoma and small cell lung cancer (SCLC). A number of important prognostic characteristics have been identified to include the extend of disease and especially for SCLC, tumor sensitivity to chemotherapy. The monoclonal antibody MOC-1 is reactive with lung cancer associated antigens and stains neural and a variable number of endocrine tissues. In the lung it reacts preferentially with SCLC and carcinoids. MOC-1 was defined as a cluster I antibody during the First International Workshop on Small Cell Lung Cancer (SCLC) Antibodies. MOC-1 recognizes NCAM which is present in small cell lung cancer (SCLC) and lung carcinoids.
Clone: MOC-1
Isotype: Mouse IgG1
Source: MOC-1 is a Mouse monoclonal IgG1 antibody and is coming from a small cell lung carcinoma derived cell line prepaRation. Hybridoma's: Mouse myeloma X 63-BALB/c.
Reactivity: human, mouse
Specificity: MOC-1 is reactive with almost all SCLC cases and has a molecular weight of about 145 kD.
Form: Each vial contains 100ul of purified monoclonal antibody containing 0.09% sodium azide.
Applications: Flow Cytometry, Immunocytochemistry, Immunohistochemistry (frozen), Western blotting
Storage: Store at 4C, or in small aliquots at -20C.
Lung cancer is a heterogeneous disease, which can be subdivided into five major tyoes based on histopathological criteria like squamous cell carcinomas, adenocarcinoma, large cell carcinoma, adenosquamous carcinoma and small cell lung cancer (SCLC). A number of important prognostic characteristics have been identified to include the extend of disease and especially for SCLC, tumor sensitivity to chemotherapy. The monoclonal antibody MOC-1 is reactive with lung cancer associated antigens and stains neural and a variable number of endocrine tissues. In the lung it reacts preferentially with SCLC and carcinoids. MOC-1 was defined as a cluster I antibody during the First International Workshop on Small Cell Lung Cancer (SCLC) Antibodies. MOC-1 recognizes NCAM which is present in small cell lung cancer (SCLC) and lung carcinoids.
Clone: MOC-1
Isotype: Mouse IgG1
Source: MOC-1 is a Mouse monoclonal IgG1 antibody and is coming from a small cell lung carcinoma derived cell line prepaRation. Hybridoma's: Mouse myeloma X 63-BALB/c.
Reactivity: human, mouse
Specificity: MOC-1 is reactive with almost all SCLC cases and has a molecular weight of about 145 kD.
Form: Each vial contains 100ul of purified monoclonal antibody containing 0.09% sodium azide.
Applications: Flow Cytometry, Immunocytochemistry, Immunohistochemistry (frozen), Western blotting
Storage: Store at 4C, or in small aliquots at -20C.
| Is Featured? | No |
|---|
Write Your Own Review